The second federal bellwether trial over transvaginal mesh devices has settled for an undisclosed sum, while manufacturer C.R. Bard Inc. continues to press that the FDA's approval of its device should be admitted as evidence to jurors.
Transvaginal Mesh Bellwether Case Ends in Settlement
The Litigation Daily
August 26, 2013